Therapeutic nanoparticles to combat cancer drug resistance.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current drug metabolism

• Publication date

  2009-09-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/138920009790274540PMID 20214578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A DNA nanomachine that maps spatial and temporal pH changes inside living cells.

  2009cited by this paper
• Gender differences in p-glycoprotein expression and function: effects on drug disposition and outcome.

  2009cited by this paper
• Targeting of albumin-embedded paclitaxel nanoparticles to tumors.

  2009cited by this paper
• Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system.

  2009cited by this paper
• Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.

  2009cited by this paper
• Mediating tumor targeting efficiency of nanoparticles through design.

  2009cited by this paper
• Recent progress in tumor pH targeting nanotechnology.

  2008cited by this paper
• Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance.

  2008cited by this paper
• A virus-mimetic nanogel vehicle.

  2008cited by this paper
• Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.

  2008cited by this paper
• Nanoparticle-mediated cellular response is size-dependent.

  2008cited by this paper
• Nanoparticle therapeutics: an emerging treatment modality for cancer

  2008cited by this paper
• Nanoparticles in Medicine: Therapeutic Applications and Developments

  2008cited by this paper
• Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.

  2007cited by this paper
• Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.

  2007cited by this paper
• Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.

  2007cited by this paper
• Nanocarriers as an emerging platform for cancer therapy.

  2007cited by this paper
• Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates

  2007cited by this paper
• A primer on the mechanics of P-glycoprotein the multidrug transporter.

  2007cited by this paper
• Nanotechnology: Intelligent Design to Treat Complex Disease

  2006cited by this paper
• Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.

  2006cited by this paper
• Multivalent effects of RGD peptides obtained by nanoparticle display.

  2006cited by this paper
• A reactive poly(ethylene glycol) layer to achieve specific surface plasmon resonance sensing with a high S/N ratio: the substantial role of a short underbrushed PEG layer in minimizing nonspecific adsorption.

  2005cited by this paper
• Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention.

  2005cited by this paper
• Recent advances with liposomes as pharmaceutical carriers

  2005cited by this paper
• Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).

  2004cited by this paper
• Multidrug resistance in cancer chemotherapy

  2004influential reference
• On the formulation of pH-sensitive liposomes with long circulation times.

  2004cited by this paper
• "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.

  2004cited by this paper
• Noninvasive imaging of quantum dots in mice.

  2004cited by this paper
• Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.

  2004cited by this paper
• Pharmacokinetics of Pegylated Liposomal Doxorubicin

  2003cited by this paper
• Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs.

  2002cited by this paper
• Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization.

  2002cited by this paper
• By-passing of P-glycoprotein Using Immunoliposomes

  2002cited by this paper
• A tumor-homing peptide with a targeting specificity related to lymphatic vessels

  2002cited by this paper
• Mechanisms of cancer drug resistance.

  2002influential reference
• Polymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs.

  2002cited by this paper
• The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

  2001cited by this paper
• PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.

  2001cited by this paper
• Tumor targeting using anti-her2 immunoliposomes.

  2001cited by this paper
• Liposome targeting to tumors using vitamin and growth factor receptors.

  2000cited by this paper
• Uptake of Long-Circulating Immunoliposomes, Directed Against Colon Adenocarcinoma Cells, by Liver Metastases of Colon Cancer

  2000cited by this paper
• Design of folic acid-conjugated nanoparticles for drug targeting.

  2000cited by this paper
• Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide

  2000cited by this paper
• Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.

  2000cited by this paper
• Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.

  2000cited by this paper
• Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting

  1999cited by this paper
• Possibility of active targeting to tumor tissues with liposomes.

  1999cited by this paper
• Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.

  1999cited by this paper
• Size of IgG-opsonized particles determines macrophage response during internalization.

  1998cited by this paper
• Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.

  1998cited by this paper
• Implications of acidic tumor microenvironment for neoplastic growth and cancer treatment: a computer analysis.

  1996cited by this paper
• Barriers to drug delivery in solid tumors.

  1994cited by this paper
• Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

  1993cited by this paper
• Modulation of doxorubicin resistance in multidrug‐resistant cells by liposomes

  1993cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper
• Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

  1975cited by this paper
• Response of dogs to repeated intravenous injection of polyethylene glycol 4000 with notes on excretion and sensitization.

  1971cited by this paper

• A narrative review on lipid-polymer hybrid nanoparticles for geriatric oncology: advancing drug delivery in the aging population

  2025cites this paper
• Zein–sodium caseinate–diosmin nanoparticles as a promising anti-cancer agent with targeted efficacy against A2780 cell line

  2025cites this paper
• How Artificial Intelligence Assists in Overcoming Drug Resistance?

  2025cites this paper
• STIMULI-RESPONSIVE DRUG DELIVERY SYSTEMS: EXTENSIVE OVERVIEW

  2025cites this paper
• Peptide-Based Therapeutic Platforms for Addressing Drug Resistance in Breast Cancer

  2025cites this paper
• Drug Repositioning in Doxorubicin-Induced Cardiotoxicity Protection

  2025cites this paper
• Folate titanium (IV)-chitosan nanocomposites as drug delivery system for active-targeted cancer therapy: Design, HSA/GSH binding, mechanistic, and biological investigations

  2024cites this paper
• Evaluation of anti-tumor activity of molybdenum disulfide nanoflowers per se and in combination with berberine against mammary gland cancer in rats

  2024cites this paper
• Zwitterionic Injectable Hydrogel-Combined Chemo- and Immunotherapy Medicated by Monomolecular Micelles to Effectively Prevent the Recurrence of Tumor Post Operation.

  2024cites this paper
• Picoplatin (II)-loaded chitosan nanocomposites as effective drug delivery systems: Preparation, mechanistic investigation of BSA/5-GMP/GSH binding and biological evaluations.

  2024cites this paper
• Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy

  2024cites this paper
• GSH-responsive and folate receptor-targeted pyridine bisfolate-encapsulated chitosan nanoparticles for enhanced intracellular drug delivery in MCF-7 cells.

  2024cites this paper
• A comprehensive review on the applications of ferrite nanoparticles in the diagnosis and treatment of breast cancer

  2024cites this paper
• An approach for an enhanced anticancer activity of ferulic acid-loaded polymeric micelles via MicroRNA-221 mediated activation of TP53INP1 in caco-2 cell line

  2024cites this paper
• Magic shotgun over magic bullet for treatment of ovarian cancer via polymeric nanoparticles

  2023cites this paper
• Lipid-based nanoparticle-mediated combination therapy for breast cancer management: a comprehensive review

  2023cites this paper
• Stability-Enhanced Cisplatin Gold Nanoparticles As Therapeutic Anticancer Agents.

  2023cites this paper
• A review on lipid-based nanocarriers mimicking chylomicron and their potential in drug delivery and targeting infectious and cancerous diseases

  2023cites this paper
• The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles.

  2023cites this paper
• Preparation and Characterization of Silver Nanoparticle Cross-linked Polymeric Cages by Freshwater Cyanobacteria and their Bactericidal Evaluation against Multi-Drug Resistant Bacteria

  2023cites this paper
• 5-Fluorouracil crystal-incorporated, pH-responsive, and release-modulating PLGA/Eudragit FS hybrid microparticles for local colorectal cancer-targeted chemotherapy.

  2023cites this paper
• Nanocracker capable of simultaneously reversing both P-glycoprotein and tumor microenvironment.

  2023cites this paper
• Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals

  2023cites this paper
• Polyethyleneimine/polyethylene glycol–conjugated gold nanoparticles as nanoscale positive/negative controls in nanotoxicology: testing in frog embryo teratogenesis assay–Xenopus and mammalian tissue culture system

  2023cites this paper
• Nanoparticle-mediated cancer cell therapy: basic science to clinical applications

  2023cites this paper
• Liposomes in the Targeted Gene Therapy of Cancer: A Critical Review.

  2022cites this paper
• Magnetoelectric core–shell CoFe2O4@BaTiO3 nanorods: their role in drug delivery and effect on multidrug resistance pump activity in vitro

  2022cites this paper
• Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer

  2022cites this paper
• Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances

  2022cites this paper
• MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets

  2021cites this paper
• Polymeric micelles and nanomedicines: Shaping the future of next generation therapeutic strategies for infectious diseases

  2021cites this paper
• Emerging nanotechnology based combination therapies of taxanes for multiple drug-resistant cancers

  2021cites this paper
• Application of chitosan modified nanocarriers in breast cancer.

  2021cites this paper
• Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics

  2021cites this paper
• Resveratrol‐loaded nanomedicines for cancer applications

  2021cites this paper
• Titanium dioxide nanotubes conjugated with quercetin function as an effective anticancer agent by inducing apoptosis in melanoma cells

  2021cites this paper
• In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles.

  2021cites this paper
• Recent Advances in the Local Drug Delivery Systems for Improvement of Anticancer Therapy.

  2021cites this paper
• Selective Integrin Ligands Promote Cell Internalization of the Antineoplastic Agent Fluorouracil

  2021cites this paper
• Rationale design of a layer-by-layer nanostructure for X-ray induced photodynamic therapy

  2020cites this paper
• Recent Emergence of Rhenium(I) Tricarbonyl Complexes as Photosensitisers for Cancer Therapy

  2020cites this paper
• Functional Bionanomaterials: From Biomolecules to Nanoparticles

  2020cites this paper
• Naringin in Combination with Isothiocyanates as Liposomal Formulations Potentiates the Anti-inflammatory Activity in Different Acute and Chronic Animal Models of Rheumatoid Arthritis

  2020cites this paper
• Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics

  2020cites this paper
• The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target

  2020cites this paper
• Polymeric micelle-based drug delivery systems for tuberculosis treatment

  2020cites this paper
• Novel Therapeutic Approaches to Treat Brain Cancer Combining Cold Atmospheric Plasma, Therapeutic Prodrugs and Gold Nanoparticles

  2020cites this paper
• TiO2 nanoparticles enhance the chemotherapeutic effects of 5-fluorouracil in human AGS gastric cancer cells via autophagy blockade.

  2020cites this paper
• Fluorescent Polysaccharide Nanogels for the Detection of Tumor Heterogeneity in Drug‐Surviving Cancer Cells

  2020cites this paper
• Nanotechnology-based targeted drug delivery systems and drug resistance in colorectal cancer

  2020cites this paper
• Parallel Multiparameter Study of PEI-Functionalized Gold Nanoparticle Synthesis for Biomedical Applications: Part 2. Elucidating the Role of Surface Chemistry and Polymer Structure in Performance.

  2020cites this paper
• Biosynthesis, Mechanisms, and Biomedical Applications of Silver Nanoparticles

  2020cites this paper
• Combination Strategies for Targeted Delivery of Nanoparticles for Cancer Therapy

  2019cites this paper
• Self-Assembled Indomethacin Dimer Nanoparticles Loaded with Doxorubicin for Combination Therapy in Resistant Breast Cancer.

  2019cites this paper
• Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future

  2019cites this paper
• Preparation and Evaluation of mPEG-PLGA Block Copolymer Micelles Loaded with a Sarsasapogenin Derivative

  2019cites this paper
• In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.

  2019cites this paper
• Boron nitride nanotube-CREKA peptide as an effective target system to metastatic breast cancer

  2019cites this paper
• Multifunctional MIL-Cur@FC as a theranostic agent for magnetic resonance imaging and targeting drug delivery: in vitro and in vivo study

  2019cites this paper
• Advances in nanocarriers as drug delivery systems in Chagas disease

  2019cites this paper
• Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer

  2019cites this paper
• Recent advances in nanoparticles-based strategies for cancer therapeutics and antibacterial applications

  2019cites this paper
• Nanomaterials multifunctional behavior for enlighten cancer therapeutics.

  2019cites this paper
• PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution

  2019cites this paper
• Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted-Delivery of Doxorubicin to Glioblastoma.

  2019cites this paper
• Nanoparticles delivery to cancer: Approaches and limitation

  2019cites this paper
• PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution

  2019cites this paper
• Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer.

  2019cites this paper
• Poly(Ferulic Acid) with an Anticancer Effect as a Drug Nanocarrier for Enhanced Colon Cancer Therapy

  2019cites this paper
• Nanotechnology Toward Treating Cancer

  2019cites this paper
• Recent Advances on Cellulose-Based Nano-Drug Delivery Systems: Design of Prodrugs and Nanoparticles.

  2019cites this paper
• Microfluidic device for the analysis of MDR cancerous cell-derived exosomes’ response to nanotherapy

  2019cites this paper
• Implications of nanotechnology for the treatment of cancer: Recent advances.

  2019cites this paper
• Design of new nanocarriers for biomedical applications

  2018cites this paper
• Microemulsion Assisted Sol-Gel Method as Approach to Load a Model Anticancer Drug inside Silica Nanoparticles for Controlled Release Applications

  2018cites this paper
• Surface Modification of Cisplatin-Complexed Gold Nanoparticles and Its Influence on Colloidal Stability, Drug Loading, and Drug Release.

  2018cites this paper
• Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment

  2018cites this paper
• Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells

  2018cites this paper
• Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery

  2018cites this paper
• Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor

  2018cites this paper
• Intracellular self-disassemble polysaccharide nanoassembly for multi-factors tumor drug resistance modulation of doxorubicin.

  2018cites this paper
• Nanoformulations of doxorubicin: how far have we come and where do we go from here?

  2018cites this paper
• Active-targeting docetaxel-loaded mixed micelles for enhancing antitumor efficacy

  2018cites this paper
• Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy

  2018cites this paper
• Tumor-penetrating peptides

  2018cites this paper
• Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery.

  2017cites this paper
• Co-delivery of Vorinostat and Etoposide Via Disulfide Cross-Linked Biodegradable Polymeric Nanogels: Synthesis, Characterization, Biodegradation, and Anticancer Activity

  2017cites this paper
• Nanotechnologies for brain tumor therapy

  2017cites this paper
• Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.

  2017cites this paper
• Combination antitumor therapy with targeted dual‐nanomedicines☆

  2017cites this paper
• Effect of BN Nanoparticles Loaded with Doxorubicin on Tumor Cells with Multiple Drug Resistance.

  2017cites this paper
• Recent advances in CO2 bubble-generating carrier systems for localized controlled release.

  2017cites this paper
• Development of a hybrid paclitaxel-loaded arsenite nanoparticle (HPAN) delivery system for synergistic combined therapy of paclitaxel-resistant cancer

  2017cites this paper
• Selection and optimization of nano‐formulation of P‐glycoprotein inhibitor for reversal of doxorubicin resistance in COLO205 cells

  2017cites this paper
• Chapter 8 – Nanoparticle System for Anticancer Drug Delivery: Targeting to Overcome Multidrug Resistance

  2017cites this paper
• Tumor penetrating peptides for improved drug delivery

  2017cites this paper
• FORMULATION AND EVALUATION OF ISORHAMNETIN LOADED POLY LACTIC-CO-GLYCOLIC ACID NANOPARTICLES

  2017cites this paper
• MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers.

  2017cites this paper
• Polymeric mixed micelles as nanomedicines: Achievements and perspectives.

  2017influential citation
• Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment

  2017cites this paper